Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
6
×
detroit blog main
detroit top stories
eli lilly
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
pfizer
clinical trials
genentech
johnson & johnson
bristol-myers squibb
cancer
cancer immunotherapy
gene therapy
medicare
novartis
What
bio
roundup
companies
days
drug
fda
known
news
price
airport
alzheimer’s
annual
apocalypse
approved
arena’s
august
beds
biopharma
biotech
bounty
busy
celgene
cig
comeback
congress
congressional
corner
crispr
deals
decisions
delivered
devices
different
digital
disease
drugs
epidemic
executives
expressing
fail
Language
unset
Current search:
celgene
×
photo
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More